tocilizumab,venetoclax
abbvie,roche
['toci', 'mds', 'leusm', 'aml,(-streamline),(-seamless),(-kamloops),(-latamleaders),(-dreamlike)', 'venetoclax']
congress | #ash22
patrick reville presents phase ii data of intensive ven+clia in 67 patients 65 years with nd aml/hr-mds. crc = 96%, estimated 24-month os = 71% + efs = 68%. 90% achieved mrd negativity on study, and 78% experienced febrile neutropenia.
#leusm #mdssm 
The AML Hub is an evidence-based online resource on Acute Myeloid Leukemia (AML), for academic researchers and treating clinicians. #leusm